Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elke, Jager"'
Autor:
Paola Nisticò, Pier Giorgio Natali, Angela Santoni, Elke Jager, Claudio Botti, Irene Venturo, Letizia Perracchio, Flavia Novelli, Andrea Conidi, Anna Di Benedetto, Marcella Mottolese, Francesca Di Modugno
Supplementary Figure Legend from The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb031e5bd3b5828cc489c9e2aad627f
https://doi.org/10.1158/1078-0432.22440967.v1
https://doi.org/10.1158/1078-0432.22440967.v1
Autor:
Paola Nisticò, Pier Giorgio Natali, Angela Santoni, Elke Jager, Claudio Botti, Irene Venturo, Letizia Perracchio, Flavia Novelli, Andrea Conidi, Anna Di Benedetto, Marcella Mottolese, Francesca Di Modugno
Supplementary Figure 1 from The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5043c698651df0515fe8dc9ebf90b589
https://doi.org/10.1158/1078-0432.22440970
https://doi.org/10.1158/1078-0432.22440970
Autor:
Paola Nisticò, Pier Giorgio Natali, Angela Santoni, Elke Jager, Claudio Botti, Irene Venturo, Letizia Perracchio, Flavia Novelli, Andrea Conidi, Anna Di Benedetto, Marcella Mottolese, Francesca Di Modugno
Purpose: hMena (ENAH), a cytoskeleton regulatory protein involved in the regulation of cell motility and adhesion, is overexpressed in breast cancer. The aim of this study was to define at what stage of breast carcinogenesis hMena is overexpressed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d279dd56c9753f1a20ace022f1d058b8
https://doi.org/10.1158/1078-0432.c.6518176.v1
https://doi.org/10.1158/1078-0432.c.6518176.v1
Autor:
Agnete Brunsvik Fredriksen, Anja Williams, Hedda Wold, Monika Sekelja, Karoline W. Schjetne, Mads Axelsen, Elke Jager, Lisa Gerner, Jürgen Krauss, Angela M. Krackhardt
Publikováno v:
Cancer Research. 79:CT217-CT217
BACKGROUND: Neoantigens are ideal for developing personalized cancer vaccines as they are tumor specific and not subject to central tolerance. Targeting neoantigens to generate potent tumor-specific T-cell responses has shown both promising preclinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feb7da603394a0832fd6cec6ec7bac3b
https://doi.org/10.1158/1538-7445.am2019-ct217
https://doi.org/10.1158/1538-7445.am2019-ct217
Autor:
Elke Jager, Yao-Tseng Chen, Yasuhiro Nagata, P R Dunbar, Elizabeth Stockert, Alexander Knuth, Sacha Gnjatic, Lloyd J. Old, Uzi Gileadi, Vincenzo Cerundolo, Dennis Panicali, Ji-Li Chen
Publikováno v:
Scopus-Elsevier
Expression of NY-ESO-1 in a high proportion of different human tumors makes this protein a very attractive vaccine target. NY-ESO-1 peptides, recognized by HLA-A2-restricted CTL, have recently been described. However, it remains unclear how efficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a9704b51f55385fd7647c301625e85
https://ora.ox.ac.uk/objects/uuid:dc334ae1-e1b9-43bc-b55b-2337036e8658
https://ora.ox.ac.uk/objects/uuid:dc334ae1-e1b9-43bc-b55b-2337036e8658
Autor:
Lucas, Serrano, Eleftherios, Archavlis, Elke, Januschek, Pavel, Timofeev, Elke, Jager, Peter, Ulrich
Publikováno v:
Journal of neurosurgical sciences. 60(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb8db8ae08ecb28b4ed63a5f058df090
https://pubmed.ncbi.nlm.nih.gov/27402411
https://pubmed.ncbi.nlm.nih.gov/27402411
Autor:
Dennis Panicali, Armin Bender, Linda Pan, Danila Valmori, Julia Karbach, Lloyd J. Old, Erika Ritter, Sacha Gnjatic, Antje Neumann, Maha Ayyoub, Gerd Ritter, Herbert F. Oettgen, Dirk Jäger, Alexander Knuth, Eric A. Hoffman, Elke Jager
Publikováno v:
Proceedings of the National Academy of Sciences. 103:14453-14458
NY-ESO-1 is a cancer/testis antigen expressed in a range of human malignancies, and a number of vaccine strategies targeting NY-ESO-1 are being developed. In the present study, the safety and immunogenicity of recombinant vaccinia-NY-ESO-1 and recomb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f65f096695e7da4d8b513b4cc2fcdc5
https://doi.org/10.1073/pnas.0606512103
https://doi.org/10.1073/pnas.0606512103
Autor:
Julia Karbach, Elisabeth Stockert, Ivan Gout, Elke Jager, Alexander Knuth, Matthew J. Scanlan, Lloyd J. Old, Michael Arand, Yao-Tseng Chen
Publikováno v:
Journal of Experimental Medicine. 187:1349-1354
Evidence is growing for both humoral and cellular immune recognition of human tumor antigens. Antibodies with specificity for antigens initially recognized by cytotoxic T lymphocytes (CTLs), e.g., MAGE and tyrosinase, have been detected in melanoma p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3240ffe1ed55977d799d4f604e2d0603
https://doi.org/10.1084/jem.187.8.1349
https://doi.org/10.1084/jem.187.8.1349
Autor:
Antje Neumann, Elke Jager
Publikováno v:
Krankheit: Lernen im Ausnahmezustand? ISBN: 9783642282003
Die Durchfuhrung klinischer Studien unterliegt umfassenden gesetzlichen Bestimmungen. Die einzelnen Entwicklungs- und Studienphasen neuer Medikamente erfordern die Berucksichtigung sowohl der Rechtslage als auch der individuellen Krankheitssituation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::132f3caec522e91bc4393106f62026b6
https://doi.org/10.1007/978-3-642-28201-0_29
https://doi.org/10.1007/978-3-642-28201-0_29
Autor:
Elke Jager, Mark Ringhoffer, Alexander Knuth, Michael Arand, Franz Oesch, Manfred Hagedorn, Julia Karbach, Dirk Jäger, Christiane Ilsemann
Publikováno v:
ResearcherID
Antigenic peptides derived from several differentiation antigens of the melanocyte lineage were recently identified in human melanomas as targets for HLA-A2.1-restricted cytotoxic T lymphocytes (CTLs). To examine their potential role in tumour-direct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aa0911281ea225c943f6eb8250ef0d4
https://doi.org/10.1097/00008390-199612000-00003
https://doi.org/10.1097/00008390-199612000-00003